Scholars@Duke

A Study of Dapansutrile Plus Pembrolizumab in Patients with PD-1 Refractory Advanced Melanoma

Clinical Trial Grant
Duke Scholars
April Kelly Scott Salama
Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Awarded By

Merck & Co., Inc.

Start Date

August 10, 2022

End Date

August 13, 2026
 

Awarded By

Merck & Co., Inc.

Start Date

August 10, 2022

End Date

August 13, 2026